A clinical trial of super-stable homogeneous lipiodol-nanoICG formulation-guided precise fluorescent laparoscopic hepatocellular carcinoma resection
Open Access
- 3 June 2022
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 20 (1) , 1-13
Abstract
Background: Applying traditional fluorescence navigation technologies in hepatocellular carcinoma is severely restricted by high false-positive rates, variable tumor differentiation, and unstable fluorescence performance.Results: In this study, a green, economical and safe nanomedicine formulation technology was developed to construct carrier-free indocyanine green nanoparticles (nanoICG) with a small uniform size and better fluorescent properties without any molecular structure changes compared to the ICG molecule. Subsequently, nanoICG dispersed into lipiodolviaa super-stable homogeneous intermixed formulation technology (SHIFT&nanoICG) for transhepatic arterial embolization combined with fluorescent laparoscopic hepatectomy to eliminate the existing shortcomings. A 52-year-old liver cancer patient was recruited for the clinical trial of SHIFT&nanoICG. We demonstrate that SHIFT&nanoICG could accurately identify and mark the lesion with excellent stability, embolism, optical imaging performance, and higher tumor-to-normal tissue ratio, especially in the detection of the microsatellite lesions (0.4 × 0.3 cm), which could not be detected by preoperative imaging, to realize a complete resection of hepatocellular carcinoma under fluorescence laparoscopy in a shorter period (within 2 h) and with less intraoperative blood loss (50 mL).Conclusions: This simple and effective strategy integrates the diagnosis and treatment of hepatocellular carcinoma, and thus, it has great potential in various clinical applications.Keywords
Funding Information
- Nuclear medicine and molecular imaging key laboratory of sichuan province open project (HYX20003)
- Chengdu Gaoxin Medical Association 2020 Annual Cancer Intervention Special Research Fund (2020S02)
- National Natural Science Foundation of China (81925019, 81422023, 82003147, 81603015, 81871404, 82003147 and U1705281)
- Major State Basic Research Development Program of China (2017YFA0205201)
- Fundamental Research Funds for the Central Universities (20720190088, 20720200019)
This publication has 36 references indexed in Scilit:
- Hypervascular Benign and Malignant Liver Tumors That Require Differentiation from Hepatocellular Carcinoma: Key Points of Imaging DiagnosisLiver Cancer, 2014
- First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent: a pilot studyTranslational Research, 2013
- Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imagingBiomaterials, 2012
- Nuclear Mapping of Nanodrug Delivery Systems in Dynamic Cellular EnvironmentsACS Nano, 2012
- Rapid Cancer Detection by Topically Spraying a γ-Glutamyltranspeptidase–Activated Fluorescent ProbeScience Translational Medicine, 2011
- Ring-opening metathesis polymerization-based synthesis of polymeric nanoparticles for enhanced tumor imaging in vivo: Synergistic effect of folate-receptor targeting and PEGylationBiomaterials, 2010
- A novel image‐guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigationJournal of Surgical Oncology, 2009
- Near-Infrared Emitting Fluorophore-Doped Calcium Phosphate Nanoparticles for In Vivo Imaging of Human Breast CancerACS Nano, 2008
- Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinomaEuropean Journal of Surgical Oncology, 2006
- Role of Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma: Relation between Postoperative Course and the Pattern of Tumor RecurrenceWorld Journal of Surgery, 2003